Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:11 PM
Study NCT ID:
NCT00403156
Status:
WITHDRAWN
Last Update Posted:
2015-12-31
First Post:
2006-11-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor:
Vitreous -Retina- Macula Consultants of New York
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FVF3989S
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Richard Spaide, MD
Old Organization:
Vitreous Retina Macula Consultants of New York
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |